Cryoport (CYRX) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CYRX shares.
View CYRX analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 1 year price targets for Cryoport's shares. Their CYRX share price forecasts range from $28.00 to $30.00. On average, they anticipate the company's share price to reach $29.50 in the next twelve months. This suggests a possible upside of 60.8% from the stock's current price.
View analysts price targets for CYRX or view top-rated stocks among Wall Street analysts.

Cryoport's stock was trading at $17.35 at the beginning of the year. Since then, CYRX shares have increased by 5.8% and is now trading at $18.35.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CYRX earnings forecast.

Cryoport, Inc. (NASDAQ:CYRX) announced its earnings results on Thursday, May, 4th. The consumer goods maker reported ($0.16) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.02. The consumer goods maker earned $62.82 million during the quarter, compared to analyst estimates of $62.15 million. Cryoport had a negative trailing twelve-month return on equity of 4.90% and a negative net margin of 11.91%. The firm's revenue for the quarter was up 20.1% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.31) EPS.

ETFs with the largest weight of Cryoport (NASDAQ:CYRX) stock in their portfolio include Principal Healthcare Innovators ETF (BTEC), Pacer Industrials and Logistics ETF (SHPP),

Cryoport updated its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $270.00 million-$290.00 million, compared to the consensus revenue estimate of $273.56 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ).

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Cryoport's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (16.44%), BlackRock Inc. (6.96%), Impax Asset Management Group plc (5.54%), Fred Alger Management LLC (5.30%), Macquarie Group Ltd. (3.08%) and Macquarie Group Ltd. (3.08%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, Robert J Hariri and Robert Stefanovich.
View institutional ownership trends.

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CYRX stock can currently be purchased for approximately $18.35.

Cryoport (NASDAQ:CYRX) has a market capitalization of $835.66 million and generates $237.28 million in revenue each year. The consumer goods maker earns $-37,330,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis.

The company employs 1,024 workers across the globe.

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The official website for the company is www.cryoport.com. The consumer goods maker can be reached via phone at (949) 470-2300, via email at tfromer@kcsa.com, or via fax at 949-470-2306.